OneDigital Investment Advisors LLC Has $5.27 Million Position in STERIS plc (NYSE:STE)

OneDigital Investment Advisors LLC grew its position in STERIS plc (NYSE:STE - Free Report) by 335.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,727 shares of the medical equipment provider's stock after acquiring an additional 16,737 shares during the quarter. OneDigital Investment Advisors LLC's holdings in STERIS were worth $5,270,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of STE. Massachusetts Financial Services Co. MA raised its stake in STERIS by 13.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 6,442,805 shares of the medical equipment provider's stock worth $1,414,453,000 after acquiring an additional 778,613 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in STERIS by 7,418.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 309,771 shares of the medical equipment provider's stock valued at $75,132,000 after purchasing an additional 305,651 shares during the last quarter. Impax Asset Management Group plc grew its stake in STERIS by 29.7% during the second quarter. Impax Asset Management Group plc now owns 1,150,517 shares of the medical equipment provider's stock worth $251,663,000 after buying an additional 263,383 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of STERIS by 1,946.3% during the second quarter. American Century Companies Inc. now owns 270,311 shares of the medical equipment provider's stock worth $59,344,000 after buying an additional 257,101 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of STERIS by 7.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 1,738,630 shares of the medical equipment provider's stock valued at $390,880,000 after acquiring an additional 120,616 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Insider Activity at STERIS

In other STERIS news, CFO Michael J. Tokich sold 23,332 shares of the firm's stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the sale, the chief financial officer now directly owns 42,930 shares in the company, valued at approximately $10,603,710. This trade represents a 35.21 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.14% of the company's stock.

STERIS Trading Down 0.5 %

NYSE STE traded down $1.07 during trading hours on Friday, hitting $220.12. The company's stock had a trading volume of 540,421 shares, compared to its average volume of 492,687. STERIS plc has a twelve month low of $195.47 and a twelve month high of $248.24. The firm has a market capitalization of $21.73 billion, a P/E ratio of 50.26 and a beta of 0.85. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The stock has a fifty day moving average of $230.37 and a 200 day moving average of $228.26.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping analysts' consensus estimates of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.33 billion. During the same period in the previous year, the firm earned $2.03 earnings per share. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. Equities research analysts forecast that STERIS plc will post 9.15 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be paid a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.04%. The ex-dividend date is Tuesday, November 19th. STERIS's payout ratio is 52.05%.

Analysts Set New Price Targets

STE has been the subject of a number of recent analyst reports. Stephens reaffirmed an "overweight" rating and set a $260.00 price target on shares of STERIS in a report on Thursday, November 7th. Piper Sandler upgraded shares of STERIS from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $230.00 to $260.00 in a research report on Thursday, October 24th. JMP Securities restated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research report on Wednesday, August 7th. StockNews.com lowered shares of STERIS from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, October 29th. Finally, Needham & Company LLC reissued a "hold" rating on shares of STERIS in a report on Friday, November 8th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $253.00.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.